From: MicroRNA-1202 plays a vital role in osteoarthritis via KCNQ1OT1 has-miR-1202-ETS1 regulatory pathway
Cluster | GO | P value | Count | Symbol |
---|---|---|---|---|
hsa-miR-1202 | GO:0070412 R-SMAD binding | 1.09E−02 | 1 | LDLRAD4 |
hsa-miR-1202 | GO:0008066 glutamate receptor activity | 1.28E−02 | 1 | GRM4 |
hsa-miR-1202 | GO:0035035 histone acetyltransferase binding | 1.28E−02 | 1 | ETS1 |
hsa-miR-1202 | GO:0070063 RNA polymerase binding | 1.75E−02 | 1 | PPIB |
hsa-miR-1202 | GO:0003755 peptidyl-prolyl cis-trans isomerase activity | 2.04E−02 | 1 | PPIB |
hsa-miR-1202 | GO:0016859 cis-trans isomerase activity | 2.13E−02 | 1 | PPIB |
hsa-miR-1202 | GO:0005518 collagen binding | 3.16E−02 | 1 | PPIB |
hsa-miR-1202 | GO:0046332 SMAD binding | 3.30E−02 | 1 | LDLRAD4 |
hsa-miR-1202 | GO:0051082 unfolded protein binding | 4.73E−02 | 1 | PPIB |
hsa-miR-33b-3p | GO:0003774 motor activity | 4.55E−03 | 2 | MYO3A/SMC1A |
hsa-miR-33b-3p | GO:0019215 intermediate filament binding | 1.01E−02 | 1 | SYNM |
hsa-miR-33b-3p | GO:0030898 actin-dependent ATPase activity | 1.01E−02 | 1 | MYO3A |
hsa-miR-33b-3p | GO:0034236 protein kinase A catalytic subunit binding | 1.16E−02 | 1 | PRKAR1A |
hsa-miR-33b-3p | GO:0000146 microfilament motor activity | 1.70E−02 | 1 | MYO3A |
hsa-miR-33b-3p | GO:0001221 transcription cofactor binding | 1.70E−02 | 1 | RORA |
hsa-miR-33b-3p | GO:0030552 cAMP binding | 1.85E−02 | 1 | PRKAR1A |
hsa-miR-33b-3p | GO:0030291 protein serine/threonine kinase inhibitor activity | 2.23E−02 | 1 | PRKAR1A |
hsa-miR-33b-3p | GO:0043531 ADP binding | 2.53E−02 | 1 | MYO3A |
hsa-miR-33b-3p | GO:0030551 cyclic nucleotide binding | 2.76E−02 | 1 | PRKAR1A |
hsa-miR-33b-3p | GO:0005484 SNAP receptor activity | 2.91E−02 | 1 | STX16 |
hsa-miR-33b-3p | GO:0008307 structural constituent of muscle | 3.06E−02 | 1 | SYNM |
hsa-miR-33b-3p | GO:0051018 protein kinase A binding | 3.21E−02 | 1 | PRKAR1A |
hsa-miR-33b-3p | GO:0032934 sterol binding | 3.29E−02 | 1 | RORA |
hsa-miR-33b-3p | GO:0004879 RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding | 3.74E−02 | 1 | RORA |
hsa-miR-33b-3p | GO:0015296 anion:cation symporter activity | 3.74E−02 | 1 | SLC12A7 |
hsa-miR-33b-3p | GO:0098531 transcription factor activity, direct ligand regulated sequence-specific DNA binding | 3.74E−02 | 1 | RORA |
hsa-miR-33b-3p | GO:0003707 steroid hormone receptor activity | 4.41E−02 | 1 | RORA |
hsa-miR-33b-3p | GO:0003682 chromatin binding | 4.85E−02 | 2 | POU2F1/SMC1A |
hsa-miR-4281 | GO:0005337 nucleoside transmembrane transporter activity | 3.10E−03 | 1 | SLC29A2 |
hsa-miR-4281 | GO:0015932 nucleobase-containing compound transmembrane transporter activity | 6.91E−03 | 1 | SLC29A2 |
hsa-miR-4281 | GO:1901505 carbohydrate derivative transporter activity | 7.15E−03 | 1 | SLC29A2 |
hsa-miR-4281 | GO:0030674 protein binding, bridging | 3.63E−02 | 1 | BCL3 |
hsa-miR-4281 | GO:0060090 binding, bridging | 4.00E−02 | 1 | BCL3 |
hsa-miR-4284 | GO:0004114 3′,5′-cyclic-nucleotide phosphodiesterase activity | 1.64E−03 | 2 | PDE4C/PDE11A |
hsa-miR-4284 | GO:0004112 cyclic-nucleotide phosphodiesterase activity | 1.78E−03 | 2 | PDE4C/PDE11A |